These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 8854020)

  • 1. Stability of yellow fever vaccine.
    Monath TP
    Dev Biol Stand; 1996; 87():219-25. PubMed ID: 8854020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of 17D yellow fever virus vaccine using different stabilizers.
    Adebayo AA; Sim-Brandenburg JW; Emmel H; Olaleye DO; Niedrig M
    Biologicals; 1998 Dec; 26(4):309-16. PubMed ID: 10403034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term storage studies with a new stabilised formulation of yellow fever virus vaccine.
    Finter NB; Burfoot C; Young PA; Ferris R
    Dev Biol Stand; 1976 Oct; 36():279-83. PubMed ID: 1030425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of live, freeze-dried virus vaccines.
    Peetermans J; Colinet G; Bouillet A; D'Hondt E; Stephenne J
    Dev Biol Stand; 1976 Oct; 36():291-6. PubMed ID: 1030427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermostability of poliovirus and measles vaccines.
    Melnick JL
    Dev Biol Stand; 1996; 87():155-60. PubMed ID: 8854012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
    Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
    Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the stability of live oral attenuated bacterial vaccines.
    Cryz SJ; Pasteris O; Varallyay SJ; Fürer E
    Dev Biol Stand; 1996; 87():277-81. PubMed ID: 8854028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adverse storage on live virus vaccines.
    Finter NB; Ferris R; Kelly A; Prydie J
    Dev Biol Stand; 1978; 41():271-6. PubMed ID: 753656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein.
    Bonaldo MC; Garratt RC; Freire MS; Galler R
    Cell Biochem Biophys; 2006; 44(3):313-24. PubMed ID: 16679518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of rinderpest vaccine by modification of the lyophilization process.
    House JA; Mariner JC
    Dev Biol Stand; 1996; 87():235-44. PubMed ID: 8854023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat-stable measles vaccine produced by spray drying.
    Ohtake S; Martin RA; Yee L; Chen D; Kristensen DD; Lechuga-Ballesteros D; Truong-Le V
    Vaccine; 2010 Feb; 28(5):1275-84. PubMed ID: 19944152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is there an alternative to the amaril 17D vaccine?].
    Saluzzo JF
    Bull Soc Pathol Exot; 1999 Dec; 92(5 Pt 2):436. PubMed ID: 11000959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of recombinant yellow fever 17D viruses expressing foreign protein epitopes at the surface.
    Bonaldo MC; Garratt RC; Marchevsky RS; Coutinho ES; Jabor AV; Almeida LF; Yamamura AM; Duarte AS; Oliveira PJ; Lizeu JO; Camacho LA; Freire MS; Galler R
    J Virol; 2005 Jul; 79(13):8602-13. PubMed ID: 15956601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborative study to assess the suitability of a candidate International Standard for yellow fever vaccine.
    Ferguson M; Heath A
    Biologicals; 2004 Dec; 32(4):195-205. PubMed ID: 15572101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the stability of 17D-204 yellow fever vaccine before and after stabilization.
    Sood DK; Aggarwal RK; Sharma SB; Sokhey J; Singh H
    Vaccine; 1993; 11(11):1124-8. PubMed ID: 8249431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of freeze-dried and reconstituted measles vaccines.
    Peetermans J; Colinet G; Stephenne J; Bouillet A
    Dev Biol Stand; 1978; 41():259-64. PubMed ID: 753654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability characteristics of freeze-dried human live virus vaccines.
    Cowdery S; Frey M; Orlowski S; Gray A
    Dev Biol Stand; 1976 Oct; 36():297-303. PubMed ID: 1030428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.